Cohort Study Investigating the Association Between Antichlamydial Antibody Positivity and ART Outcomes in Women With TFI
NCT04139629 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 292
Last updated 2021-08-24
Summary
In a prospective cohort study investigators will examine characteristics and clinical outcomes of treatment with ART in women with tubal factor infertility (TFI) with regard to seropositivity to antichlamydial antibodies.
Conditions
- Antichlamydial Antibodies
- Chlamydia Trachomatis Infection
- Infertility
- Tubal Factor Infertility
Interventions
- DIAGNOSTIC_TEST
-
antichlamydial antibody test
At the first day of stimulation blood analyses for IgG, IgA and IgM (ELISA) to major chlamydial antigens (anti-C.trachomatis), major outer membrane protein (MOMP) and plasmid-encoded protein (pgp3) will be performed for patients found eligible for the study.
- DRUG
-
treatment of infertility with ART
COS in gonadotropin-releasing hormone (GnRH) antagonist protocol with IVF/ICSI, fresh ET and, if no pregnancy occurred, frozen/thawed ET (for all embryos resulting from this COS) will be performed.
Sponsors & Collaborators
-
D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
lead OTHER
Principal Investigators
-
Alexandr Gzgzyan, Prof, PhD · D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 41 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-25
- Primary Completion
- 2020-01-30
- Completion
- 2021-10-30
Countries
- Russia
Study Locations
More Related Trials
-
Epidemiology of Sexually Transmitted Infections and Its iMpAcT on fEmale Infertility
NCT05244967 ·Status: RECRUITING
-
Treatment of Antenatal Chlamydia Infection
NCT01946256 ·Status: COMPLETED ·Phase: PHASE2
-
The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection
NCT01081379 ·Status: UNKNOWN
-
Chlamydia Tracomatis and Other Lower Genital Tract Infections Among Women With Unexplained Early Miscarriage
NCT04152278 ·Status: COMPLETED
-
Evaluation of a Serology Diagnostic Kit for the Detection of Genital Mycoplasma in Pregnancy
NCT01281319 ·Status: UNKNOWN
-
Navigating Pregnancy and Parenthood With Lyme Disease
NCT06397794 ·Status: RECRUITING
-
Chlamydia Trachomatis Persistence in the Female Gastrointestinal Tract
NCT00578188 ·Status: WITHDRAWN
-
Evaluation of the Performance of Chembio's DPP(R) Syphilis Screen & Confirm Rapid Test System
NCT01543295 ·Status: WITHDRAWN
-
Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences
NCT04955717 ·Status: COMPLETED ·Phase: NA
-
Treatment Utility of Postpartum Antibiotics in Chorioamnionitis
NCT01585129 ·Status: TERMINATED ·Phase: PHASE4
-
Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy
NCT02129465 ·Status: UNKNOWN
-
Demographics and Outcomes of COVID 19 in Pregnancy at a Community Based Hospital
NCT04385914 ·Status: UNKNOWN
-
Primitive Immunodeficiency and Pregnancy
NCT04581460 ·Status: COMPLETED
-
Universal Screening Program for Cytomegalovirus Infection in the First Trimester of Pregnancy (CITEMB Study)
NCT05699421 ·Status: COMPLETED
-
Impact of the Microbiome on Time to Pregnancy and Pregnancy Outcomes in Fertile Women Attempting to Conceive
NCT05127252 ·Status: RECRUITING
-
Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection
NCT04707820 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes (Philani Ndiphile)
NCT04446611 ·Status: COMPLETED ·Phase: NA
-
Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study)
NCT00751621 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective, Monocentric, Interventional Study on Spontaneous Vaginal Clearance of Mycoplasma Genitalium
NCT04841408 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection
NCT01659684 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)
NCT05170269 ·Status: TERMINATED ·Phase: PHASE3
-
A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA
NCT00532324 ·Status: COMPLETED ·Phase: NA
-
Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus
NCT01251744 ·Status: COMPLETED ·Phase: NA
-
Pilot Study Freeze and Transport Immune Cells
NCT00138268 ·Status: COMPLETED
-
The Prevalence of Chlamydia Trachomatis and Neisseria Gonorrhoeae in Patients Suspected of Hemorrhagic Proctosigmoiditis
NCT07061899 ·Status: ACTIVE_NOT_RECRUITING